243 related articles for article (PubMed ID: 19036096)
1. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
[No Abstract] [Full Text] [Related]
2. Remission induction with single agent Rituximab in a child with multiply relapsed precursor-B ALL.
Morris ES; Vora A
Br J Haematol; 2007 Oct; 139(2):344-5. PubMed ID: 17897313
[No Abstract] [Full Text] [Related]
3. Prospective evaluation in children of a new medical device intended to insure the correct administration of intrathecal antineoplastic agents.
Lecomte A; Thomaré P; Courant M; Suarez A; Méchinaud F
Med Pediatr Oncol; 2003 Jul; 41(1):89-90. PubMed ID: 12764759
[No Abstract] [Full Text] [Related]
4. Rituximab as therapy for acute lymphoblastic leukemia.
Thomas DA
Clin Adv Hematol Oncol; 2010 Mar; 8(3):168-71. PubMed ID: 20400931
[No Abstract] [Full Text] [Related]
5. [Effective combination chemotherapy with rituximab for acute lymphoblastic leukemia with bone relapse after bone marrow transplantation].
Abe T; Kitajima T; Honma K; Kurasaki T; Okazuka K; Shibasaki Y; Momoi A; Kuroha T; Masuko M; Yagisawa K; Furukawa T; Toba K; Aizawa Y
Rinsho Ketsueki; 2008 Nov; 49(11):1556-61. PubMed ID: 19047788
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma.
de Vries MJ; Veerman AJ; Zwaan CM
Br J Haematol; 2004 May; 125(3):414-5. PubMed ID: 15086431
[No Abstract] [Full Text] [Related]
7. [High-risk acute lymphoblastic leukemia].
Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
[No Abstract] [Full Text] [Related]
8. Lumbar spinal fluid collections in children treated with intrathecal chemotherapy: elevated CSF protein as a diagnostic clue.
Almanjomi F; Armstrong D; Abla O; Naqvi A; Weitzman S; Hitzler J
Pediatr Blood Cancer; 2008 Aug; 51(2):295-8. PubMed ID: 18454469
[TBL] [Abstract][Full Text] [Related]
9. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
10. [Changes in body height and weight of children with long-term remission of acute lymphoblastic leukemia].
Traczewska M; Ochocka M; Palczewska I
Pediatr Pol; 1988 Nov; 63(11):739-46. PubMed ID: 3253661
[No Abstract] [Full Text] [Related]
11. [Leukoencephalopathy after the intrathecal administration of cytostatics in acute lymphatic leukemia].
Hoelzer D
Dtsch Med Wochenschr; 1994 Nov; 119(47):1637. PubMed ID: 7982375
[No Abstract] [Full Text] [Related]
12. Treatment of pediatric acute lymphoblastic leukemia.
Tucci F; Aricò M
Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
[No Abstract] [Full Text] [Related]
13. Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
van de Glind G; de Graaf S; Klein C; Cornelissen M; Maecker B; Loeffen J
Pediatr Blood Cancer; 2008 Apr; 50(4):886-8. PubMed ID: 17668865
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
Pui CH; Jeha S
Nat Rev Drug Discov; 2007 Feb; 6(2):149-65. PubMed ID: 17268486
[TBL] [Abstract][Full Text] [Related]
15. [Studies of fibronectin levels in recurrences of proliferative diseases of the hematopoietic system in children].
Matysiak M; Hryniewicz HJ; Ochocka M
Pediatr Pol; 1988 Nov; 63(11):723-7. PubMed ID: 3253659
[No Abstract] [Full Text] [Related]
16. Bone relapse in a patient with acute lymphoblastic leukaemia.
Aydogdu I; Erkurt AM; Kaya E; Kuku I
Br J Haematol; 2005 Apr; 129(2):163. PubMed ID: 15813842
[No Abstract] [Full Text] [Related]
17. Supernumerary ring chromosomes accompanied with near-tetraploidy following chemotherapy and cranial radiation in a girl with a relapsed acute lymphoblastic leukemia.
Gindina T; Kondakova E; Mamaev N
Cancer Genet Cytogenet; 2007 Oct; 178(1):82-4. PubMed ID: 17889715
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes.
Luczynski W; Krawczuk-Rybak M; Muszynska-Roslan K; Stasiak-Barmuta A; Zak J
Med Pediatr Oncol; 2002 Aug; 39(2):147-8. PubMed ID: 12116070
[No Abstract] [Full Text] [Related]
19. Rituximab with interleukin-2 after autologous bone marrow transplantation for acute lymphocytic leukemia in second remission.
Ozsahin H; Fluss J; McLin V; Wacker P; Miralbell R; Helg C
Med Pediatr Oncol; 2002 Apr; 38(4):300-1. PubMed ID: 11920807
[No Abstract] [Full Text] [Related]
20. [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
Abasq C; Duval-Modeste AB; Courville P; Joly P
Ann Dermatol Venereol; 2008; 135(6-7):509-11. PubMed ID: 18598807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
